Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Roche's Valium gets label update; trontinemab Alzheimer's trials continue as active, not recruitingSep 25Weekly roundup, 6 itemsChugai PharmaceuticaldiazepamUpdated